Etanercept versus monoclonal antibodies in axial spondyloarthritis: game over?

J Rheumatol. 2014 Oct;41(10):1899-902. doi: 10.3899/jrheum.140866.

Authors

Gaëlle Varkas¹, Dirk Elewaut²

Affiliations

¹ Department of Rheumatology, University of Ghent, Ghent, Belgium.
² Department of Rheumatology, University of Ghent, Ghent, Belgium. [email protected].

PMID: 25275090
DOI: 10.3899/jrheum.140866

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antirheumatic Agents / therapeutic use*
Etanercept / therapeutic use*
Female
Humans
Male
Spondylarthritis / drug therapy*

Substances

Antirheumatic Agents
Etanercept